Continuous Glucose Monitors to Regulate Glucose Levels in Type 2 Diabetics
Completed · Not applicable
Conditions studied: Type2 Diabetes
In brief
This study allows Type 2 diabetics to receive feedback from a continuous glucose monitor (CGM) as part of an educational program designed to help them better manage their glucose levels. Subjects will also wear an activity tracker to monitor their activity and observe its effect on their glucose levels. The educational program will involve calls from coaches to check subjects' progress and answer questions.
Key facts
- Study ID
- NCT03252964
- Run by
- Savvysherpa, Inc.
- People needed
- 52
- Starts
- 2017-07-28
- Expected to finish
- 2019-02-25
- Last updated by the study team
- 2019-05-24
Who can join
Age: 65 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Be diagnosed with type 2 diabetes
- Currently take a DPP4 inhibitor, SGLT2 inhibitor, GLP-1 agonist, and/or basal insulin
- Be able to read and understand English
- Have access to a telephone
- Have a Medicare health plan
You may not qualify if…
- Pregnant
- Blind
- Deaf
- Currently receiving chemotherapy or radiation therapy to treat cancer
- Addicted to any drugs (including alcohol, painkillers, hallucinogens, or others)
- Critically ill
- Diagnosed with or experiencing:
- Kidney disease stages 4 and 5
- End stage renal disease
- Severe liver disease
- Dementia
- Schizophrenia
- Bipolar disorder
- Autism
- An intellectual or learning disability
- Arrhythmias other than atrial fibrillation
- Congestive heart failure
- Has had a:
- Myocardial infarction within the last 6 months
- Stroke within the last 6 months
- Stroke that resulted in significant disability (e.g., unable to write clearly or walk)
Where it is running
- Rogelio Machuca, MD Family Medicine, PLLC — Las Vegas, Nevada, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.